Targeting And‐1 to overcome radiation resistance in colorectal cancer
Abstract Colorectal cancer (CRC) is a leading cause of cancer‐related death worldwide. Although overall outcomes have improved in recent decades, metastatic disease is associated with a particularly poor prognosis, underscoring a need to both identify new therapeutic modalities as well as actionable...
Saved in:
Main Author: | Daniel R. Principe (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity?
by: Jesse Fischer, et al.
Published: (2018) -
Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance
by: Jaewang Lee, et al.
Published: (2023) -
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
by: Andrea Cunha, et al.
Published: (2023) -
Angiosarcoma of the vulva following radiation for colorectal cancer
by: Madison Meyer, et al.
Published: (2021) -
Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?
by: Manuela ePolimeni, et al.
Published: (2014)